Advertisement

Topics

Apellis Pharma Nabs $60 Million to Advance APL-2 into Phase III Trials

20:00 EDT 9 Aug 2017 | BioSpace

  Life Sciences Jobs   ...

Original Article: Apellis Pharma Nabs $60 Million to Advance APL-2 into Phase III Trials

NEXT ARTICLE

More From BioPortfolio on "Apellis Pharma Nabs $60 Million to Advance APL-2 into Phase III Trials"

Quick Search
Advertisement